IFM Therapeutics

Total Funding
$82.5M
Last Round
$55.5M Series BDec 2019
Rounds
2

About

Innate immune system targeting for cancer and inflammation

Summary

It has raised $82.5M in total across 2 rounds, most recently a $55.5M Series B round in Dec 2019. Investors include Abingworth, Atlas Venture and Omega Funds.

Tech & App Stack

1 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Series BSeries BDec 2019
$55.5M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors